Pharmaceutical equivalence and stability of Furosemide tablets in Argentina
- Autores
- Brevedan, Marta Ingrid Victoria; Varillas, María Alejandra; González Vidal, Noelia Luján
- Año de publicación
- 2019
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Furosemide is a widely used diuretic, indicated in the treatment of hypertension and edema. This active pharmaceutical ingredient is classified as Class IV in the Biopharmaceutical Classification System. The World Health Organization recommends an oral dose of 40 mg. The aim of the present work was to evaluate and compare critical quality attributes, including in vitro dissolution characteristics, of eight furosemide tablet brands of Argentine market, and determine their pharmaceutical equivalence. Furthermore, this research aimed to evaluate the effect of storage (twelve months after natural aging conditions) over those critical properties. At time zero of analysis, all evaluated samples fulfilled specifications for friability, hardness, disintegration, assay, uniformity of dosage units and dissolution tests. After storage, all formulations fulfilled the assay and dissolution test specifications, with no statistical differences recorded for the obtained results. Comparison of dissolution profiles was also assessed in terms of the model independent parameter called dissolution efficiency. Highly significant differences were recorded between reference and four multisource formulations. The same differences were found at the beginning of the study (time zero) and after one year of storage. One product presented the lowest dissolution efficiency results, associated to highly significant differences when compared to the other formulations. However, the obtained results reveal that the evaluated samples complied with codified quality control tests, and consequently can be qualified as pharmaceutical equivalents. Natural aging conditions clearly not affected the stability of the evaluated products.
Fil: Brevedan, Marta Ingrid Victoria. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; Argentina
Fil: Varillas, María Alejandra. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; Argentina
Fil: González Vidal, Noelia Luján. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca; Argentina - Materia
-
DISSOLUTION
FUROSEMIDE
PHARMACEUTICAL EQUIVALENCE
STABILITY - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/113198
Ver los metadatos del registro completo
id |
CONICETDig_b964946df2f901588971d33529128856 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/113198 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Pharmaceutical equivalence and stability of Furosemide tablets in ArgentinaBrevedan, Marta Ingrid VictoriaVarillas, María AlejandraGonzález Vidal, Noelia LujánDISSOLUTIONFUROSEMIDEPHARMACEUTICAL EQUIVALENCESTABILITYhttps://purl.org/becyt/ford/2.11https://purl.org/becyt/ford/2https://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3https://purl.org/becyt/ford/1.4https://purl.org/becyt/ford/1Furosemide is a widely used diuretic, indicated in the treatment of hypertension and edema. This active pharmaceutical ingredient is classified as Class IV in the Biopharmaceutical Classification System. The World Health Organization recommends an oral dose of 40 mg. The aim of the present work was to evaluate and compare critical quality attributes, including in vitro dissolution characteristics, of eight furosemide tablet brands of Argentine market, and determine their pharmaceutical equivalence. Furthermore, this research aimed to evaluate the effect of storage (twelve months after natural aging conditions) over those critical properties. At time zero of analysis, all evaluated samples fulfilled specifications for friability, hardness, disintegration, assay, uniformity of dosage units and dissolution tests. After storage, all formulations fulfilled the assay and dissolution test specifications, with no statistical differences recorded for the obtained results. Comparison of dissolution profiles was also assessed in terms of the model independent parameter called dissolution efficiency. Highly significant differences were recorded between reference and four multisource formulations. The same differences were found at the beginning of the study (time zero) and after one year of storage. One product presented the lowest dissolution efficiency results, associated to highly significant differences when compared to the other formulations. However, the obtained results reveal that the evaluated samples complied with codified quality control tests, and consequently can be qualified as pharmaceutical equivalents. Natural aging conditions clearly not affected the stability of the evaluated products.Fil: Brevedan, Marta Ingrid Victoria. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; ArgentinaFil: Varillas, María Alejandra. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; ArgentinaFil: González Vidal, Noelia Luján. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca; ArgentinaDissolution Technologies, Inc2019-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/113198Brevedan, Marta Ingrid Victoria; Varillas, María Alejandra; González Vidal, Noelia Luján; Pharmaceutical equivalence and stability of Furosemide tablets in Argentina; Dissolution Technologies, Inc; Dissolution Technologies; 26; 4; 11-2019; 30-371521-298XCONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.14227/DT260419P30info:eu-repo/semantics/altIdentifier/url/http://dissolutiontech.com/info:eu-repo/semantics/altIdentifier/url/http://dissolutiontech.com/issues/201911/DT201911_A05.pdfinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:47:05Zoai:ri.conicet.gov.ar:11336/113198instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:47:06.297CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Pharmaceutical equivalence and stability of Furosemide tablets in Argentina |
title |
Pharmaceutical equivalence and stability of Furosemide tablets in Argentina |
spellingShingle |
Pharmaceutical equivalence and stability of Furosemide tablets in Argentina Brevedan, Marta Ingrid Victoria DISSOLUTION FUROSEMIDE PHARMACEUTICAL EQUIVALENCE STABILITY |
title_short |
Pharmaceutical equivalence and stability of Furosemide tablets in Argentina |
title_full |
Pharmaceutical equivalence and stability of Furosemide tablets in Argentina |
title_fullStr |
Pharmaceutical equivalence and stability of Furosemide tablets in Argentina |
title_full_unstemmed |
Pharmaceutical equivalence and stability of Furosemide tablets in Argentina |
title_sort |
Pharmaceutical equivalence and stability of Furosemide tablets in Argentina |
dc.creator.none.fl_str_mv |
Brevedan, Marta Ingrid Victoria Varillas, María Alejandra González Vidal, Noelia Luján |
author |
Brevedan, Marta Ingrid Victoria |
author_facet |
Brevedan, Marta Ingrid Victoria Varillas, María Alejandra González Vidal, Noelia Luján |
author_role |
author |
author2 |
Varillas, María Alejandra González Vidal, Noelia Luján |
author2_role |
author author |
dc.subject.none.fl_str_mv |
DISSOLUTION FUROSEMIDE PHARMACEUTICAL EQUIVALENCE STABILITY |
topic |
DISSOLUTION FUROSEMIDE PHARMACEUTICAL EQUIVALENCE STABILITY |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/2.11 https://purl.org/becyt/ford/2 https://purl.org/becyt/ford/3.3 https://purl.org/becyt/ford/3 https://purl.org/becyt/ford/1.4 https://purl.org/becyt/ford/1 |
dc.description.none.fl_txt_mv |
Furosemide is a widely used diuretic, indicated in the treatment of hypertension and edema. This active pharmaceutical ingredient is classified as Class IV in the Biopharmaceutical Classification System. The World Health Organization recommends an oral dose of 40 mg. The aim of the present work was to evaluate and compare critical quality attributes, including in vitro dissolution characteristics, of eight furosemide tablet brands of Argentine market, and determine their pharmaceutical equivalence. Furthermore, this research aimed to evaluate the effect of storage (twelve months after natural aging conditions) over those critical properties. At time zero of analysis, all evaluated samples fulfilled specifications for friability, hardness, disintegration, assay, uniformity of dosage units and dissolution tests. After storage, all formulations fulfilled the assay and dissolution test specifications, with no statistical differences recorded for the obtained results. Comparison of dissolution profiles was also assessed in terms of the model independent parameter called dissolution efficiency. Highly significant differences were recorded between reference and four multisource formulations. The same differences were found at the beginning of the study (time zero) and after one year of storage. One product presented the lowest dissolution efficiency results, associated to highly significant differences when compared to the other formulations. However, the obtained results reveal that the evaluated samples complied with codified quality control tests, and consequently can be qualified as pharmaceutical equivalents. Natural aging conditions clearly not affected the stability of the evaluated products. Fil: Brevedan, Marta Ingrid Victoria. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; Argentina Fil: Varillas, María Alejandra. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; Argentina Fil: González Vidal, Noelia Luján. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca; Argentina |
description |
Furosemide is a widely used diuretic, indicated in the treatment of hypertension and edema. This active pharmaceutical ingredient is classified as Class IV in the Biopharmaceutical Classification System. The World Health Organization recommends an oral dose of 40 mg. The aim of the present work was to evaluate and compare critical quality attributes, including in vitro dissolution characteristics, of eight furosemide tablet brands of Argentine market, and determine their pharmaceutical equivalence. Furthermore, this research aimed to evaluate the effect of storage (twelve months after natural aging conditions) over those critical properties. At time zero of analysis, all evaluated samples fulfilled specifications for friability, hardness, disintegration, assay, uniformity of dosage units and dissolution tests. After storage, all formulations fulfilled the assay and dissolution test specifications, with no statistical differences recorded for the obtained results. Comparison of dissolution profiles was also assessed in terms of the model independent parameter called dissolution efficiency. Highly significant differences were recorded between reference and four multisource formulations. The same differences were found at the beginning of the study (time zero) and after one year of storage. One product presented the lowest dissolution efficiency results, associated to highly significant differences when compared to the other formulations. However, the obtained results reveal that the evaluated samples complied with codified quality control tests, and consequently can be qualified as pharmaceutical equivalents. Natural aging conditions clearly not affected the stability of the evaluated products. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019-11 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/113198 Brevedan, Marta Ingrid Victoria; Varillas, María Alejandra; González Vidal, Noelia Luján; Pharmaceutical equivalence and stability of Furosemide tablets in Argentina; Dissolution Technologies, Inc; Dissolution Technologies; 26; 4; 11-2019; 30-37 1521-298X CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/113198 |
identifier_str_mv |
Brevedan, Marta Ingrid Victoria; Varillas, María Alejandra; González Vidal, Noelia Luján; Pharmaceutical equivalence and stability of Furosemide tablets in Argentina; Dissolution Technologies, Inc; Dissolution Technologies; 26; 4; 11-2019; 30-37 1521-298X CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.14227/DT260419P30 info:eu-repo/semantics/altIdentifier/url/http://dissolutiontech.com/ info:eu-repo/semantics/altIdentifier/url/http://dissolutiontech.com/issues/201911/DT201911_A05.pdf |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Dissolution Technologies, Inc |
publisher.none.fl_str_mv |
Dissolution Technologies, Inc |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842268836857905152 |
score |
13.13397 |